News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
590,761 Results
Type
Article (51546)
Company Profile (50)
Press Release (539159)
Multimedia
Podcasts (161)
Webinars (23)
Section
Business (190112)
Career Advice (1873)
Deals (23564)
Drug Delivery (106)
Drug Development (65070)
Employer Resources (124)
FDA (12703)
Job Trends (12267)
News (275853)
Policy (22975)
Tag
2027 BioCapital Standard (1)
2027 BioMidwest Elite (1)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (2)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (2798)
Academic (2)
Accelerated approval (45)
ADA (39)
Adcomms (28)
Allergies (170)
Alliances (40607)
ALS (208)
Alzheimer's disease (1646)
Antibody-drug conjugate (ADC) (472)
Approvals (13240)
Artificial intelligence (720)
ASCO (302)
Autoimmune disease (325)
Automation (57)
Bankruptcy (206)
Best Places to Work (10209)
BIO (62)
BIOSECURE Act (11)
Biosimilars (195)
Biotechnology (45)
Bladder cancer (195)
Brain cancer (66)
Breast cancer (748)
Cancer (5800)
Cardiovascular disease (461)
Career advice (1626)
Career pathing (41)
CAR-T (307)
CDC (59)
Celiac Disease (2)
Cell therapy (895)
Cervical cancer (49)
Clinical research (57380)
Collaboration (2128)
Commercialization (1)
Company closure (4)
Compensation (858)
Complete response letters (58)
COVID-19 (2511)
CRISPR (110)
C-suite (1248)
Cystic fibrosis (141)
Data (8169)
Decentralized trials (3)
Denatured (53)
Depression (155)
Dermatology (91)
Diabetes (564)
Diagnostics (5754)
Digital health (54)
Diversity (10)
Diversity, equity & inclusion (40)
Drug discovery (351)
Drug pricing (139)
Drug shortages (27)
Duchenne muscular dystrophy (274)
Earnings (79924)
Editorial (64)
Employer branding (14)
Employer resources (114)
Events (104826)
Executive appointments (1130)
FDA (16336)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (17)
Frontotemporal dementia (33)
Funding (1723)
Gene editing (225)
Generative AI (65)
Gene therapy (687)
GLP-1 (896)
Government (3653)
Grass and pollen (6)
Guidances (404)
Healthcare (15756)
Hematology (173)
HIV (85)
Huntington's disease (62)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (108)
Immunology and inflammation (243)
Immuno-oncology (96)
Indications (201)
Infectious disease (2837)
Inflammatory bowel disease (197)
Inflation Reduction Act (12)
Influenza (136)
Intellectual property (256)
Interviews (337)
IPO (11323)
IRA (37)
Job creations (2424)
Job search strategy (1336)
JPM (59)
Kidney cancer (17)
Labor market (79)
Layoffs (362)
Leadership (37)
Legal (5505)
Liver cancer (89)
Longevity (29)
Lung cancer (766)
Lymphoma (442)
Machine learning (59)
Management (42)
Manufacturing (977)
Marketing (4)
MASH (194)
Medical affairs (1)
Medical device (11046)
Medtech (11198)
Mergers & acquisitions (13399)
Metabolic disorders (1405)
mRNA (272)
Multiple sclerosis (184)
NASH (12)
Neurodegenerative disease (416)
Neuropsychiatric disorders (93)
Neuroscience (3118)
Neurotech (1)
NextGen: Class of 2026 (5185)
Non-profit (3879)
Now hiring (28)
Obesity (619)
Opinion (273)
Ovarian cancer (213)
Pain (227)
Pancreatic cancer (304)
Parkinson's disease (353)
Partnered (33)
Patents (503)
Patient recruitment (705)
Peanut (56)
People (52573)
Pharmaceutical (11)
Pharmacy benefit managers (21)
Phase 1 (17706)
Phase 2 (25120)
Phase 3 (19236)
Pipeline (9155)
Policy (266)
Postmarket research (2332)
Preclinical (7925)
Press Release (48)
Prostate cancer (335)
Psychedelics (50)
Radiopharmaceuticals (309)
Rare diseases (1054)
Real estate (4049)
Recruiting (51)
Regulatory (18753)
Reports (32)
Research institute (2261)
Resumes & cover letters (277)
Rett syndrome (46)
RNA editing (28)
RSV (82)
Schizophrenia (161)
Series A (306)
Series B (205)
Service/supplier (4)
Sickle cell disease (112)
Special edition (19)
Spinal muscular atrophy (143)
Sponsored (39)
Startups (2806)
State (2)
Stomach cancer (11)
Supply chain (104)
Tariffs (60)
The Weekly (107)
Vaccines (1123)
Venture capital (120)
Weight loss (383)
Women's health (118)
Worklife (20)
Date
Today (72)
Last 7 days (350)
Last 30 days (1824)
Last 365 days (27355)
2026 (14974)
2025 (27270)
2024 (29446)
2023 (32741)
2022 (40960)
2021 (43949)
2020 (42689)
2019 (37664)
2018 (28244)
2017 (26224)
2016 (26129)
2015 (30424)
2014 (25319)
2013 (22370)
2012 (22892)
2011 (22777)
2010 (21271)
Location
Africa (759)
Alabama (85)
Alaska (6)
Arizona (267)
Arkansas (13)
Asia (32597)
Australia (6072)
California (12432)
Canada (3297)
China (1250)
Colorado (538)
Connecticut (593)
Delaware (409)
Europe (80018)
Florida (1814)
Georgia (407)
Hawaii (3)
Idaho (42)
Illinois (1081)
India (86)
Indiana (587)
Iowa (22)
Japan (554)
Kansas (110)
Kentucky (40)
Louisiana (47)
Maine (51)
Maryland (1470)
Massachusetts (9252)
Michigan (367)
Minnesota (644)
Mississippi (7)
Missouri (137)
Montana (21)
Nebraska (20)
Nevada (134)
New Hampshire (62)
New Jersey (3353)
New Mexico (30)
New York (3305)
North Carolina (1612)
North Dakota (9)
Northern California (6252)
Ohio (393)
Oklahoma (25)
Oregon (30)
Pennsylvania (2354)
Puerto Rico (20)
Rhode Island (45)
South America (1005)
South Carolina (55)
South Dakota (1)
Southern California (5012)
Tennessee (219)
Texas (2179)
United States (44457)
Utah (359)
Vermont (1)
Virginia (302)
Washington D.C. (66)
Washington State (1068)
West Virginia (3)
Wisconsin (142)
Wyoming (2)
590,761 Results for "texas a and m university".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Job Trends
10 Companies Hiring in Texas Now
Looking for a biopharma job in Texas? Check out the
BioSpace
list of 10 companies hiring life sciences professionals like you.
April 8, 2026
·
1 min read
·
Angela Gabriel
Press Releases
MustGrow Receives Texas, Utah, and Montana Registrations for TerraSante(TM) Biofertility Product
• MustGrow has received approval from the agriculture departments of Texas, Utah, and Montana to commence sales of organic biofertility product TerraSanteTM. • Based on infield grower data, the mustard-derived TerraSanteTM biofertility product has been shown to improve crop yields, soil, and potentially the soil microbiome health for nutrient/water use efficiencies.
May 26, 2026
·
5 min read
Press Releases
ProImmune Collaborates with The University of Texas Medical Branch to Advance Infectious Disease Research
April 14, 2026
·
2 min read
Press Releases
Aclarion Announces Texas Spine Care Center as New CLARITY Site
July 7, 2026
·
6 min read
Press Releases
LGM Pharma Expands U.S. Manufacturing, Bringing Total Investment to $15M Across Texas and Colorado Sites
March 19, 2026
·
4 min read
Press Releases
Texas Biomed and Flyttr partner to advance next-generation solutions for the invasive New World screwworm
June 29, 2026
·
3 min read
Press Releases
Texas Healthcare and Bioscience Institute Releases Strategic Vision to Advance the Texas Life Sciences Ecosystem
March 30, 2026
·
3 min read
Mergers & acquisitions
Lilly wants to bridge cancer care gap with $300M ADC biotech buy
Eli Lilly is putting its obesity windfall to work again, striking a new deal to acquire CrossBridge Bio, a small Texas biotech known for its cancer tech.
April 14, 2026
·
1 min read
·
Gabrielle Masson
Mergers & acquisitions
Biopharma strikes 50+ M&As deals in H1, led by Lilly’s $25B spend
The total of 52 mergers and acquisitions for the first half of 2026 reflects what analysts, industry watchers and executives are saying over and over: M&A is back.
July 1, 2026
·
1 min read
·
Annalee Armstrong
Press Releases
Texas Children’s Researcher Awarded Grant to Advance New Ways to Prevent and Treat Alzheimer’s Disease
March 25, 2026
·
4 min read
1 of 59,077
Next
